Lead StrategistSCANPHARM A/S
Company details
- CVR number
- 16279099
- Status
- Active
- Legal form
- Public limited company (A/S)
- Industry
- Fremstilling af farmaceutiske præparater(212000)
- Founded
- 1 July 1992
- Address
- Topstykket 12, 3460 Birkerød
- Municipality
- Rudersdal
Find similar companies in the same industry and build a lead list right inside your AI.
Key figures
The latest 3 financial years from the annual reports. Amounts in Danish kroner (DKK).
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 29.7m | DKK 26.9m | DKK 22.5m |
| Net profit | DKK 963k | DKK 583k | −DKK 4.4m |
| Equity | DKK 3.0m | DKK 2.1m | DKK 1.5m |
| Employees (avg.) | 0 | 42 | 44 |
Track the trend via the API.REST API (OpenAPI)
Get all 13 years of financials right inside Claude or ChatGPT via MCP.
Similar companies
Other active companies in Fremstilling af farmaceutiske præparater in Rudersdal, close in size (employees and gross profit).
- ALK-ABELLÓ A/S
2970 Hørsholm
2,737 employees · gross profit DKK 4.2bn (2025)
- MC2 Therapeutics A/S
2970 Hørsholm
11 employees · gross profit DKK 22.2m (2025)
- Allarity Therapeutics Europe ApS
2970 Hørsholm
4 employees · gross profit -DKK 39.0m (2025)
- Breye Therapeutics ApS
2970 Hørsholm
3 employees · gross profit -DKK 7.7m (2026)
- Remecure ApS
2840 Holte
gross profit DKK 9k (2025)
- Allarity Therapeutics Denmark ApS
2970 Hørsholm
gross profit DKK 0 (2025)
- SYNACT PHARMA ApS
2840 Holte
gross profit -DKK 53.2m (2025)
- Blonor Pharma ASA
2840 Holte
See all:Fremstilling af farmaceutiske præparater (178)Rudersdal (8,759)
Full financials and history
Lead Strategist is free during the beta with 20,000 credits a month. Get every figure for this company right inside your AI or via the API.
- All 13 financial years in the database
- Balance sheet: assets, liabilities, provisions and cash
- EBIT, gross profit and reporting class
- Auditor and audit firm
Free beta · 20,000 credits a month · no card
By creating an account you accept the terms on behalf of your business.